• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为住院原因的药物相互作用的流行病学。

Epidemiology of drug-drug interactions as a cause of hospital admissions.

作者信息

Jankel C A, Fitterman L K

机构信息

University of Georgia College of Pharmacy, Athens.

出版信息

Drug Saf. 1993 Jul;9(1):51-9. doi: 10.2165/00002018-199309010-00005.

DOI:10.2165/00002018-199309010-00005
PMID:8347291
Abstract

The purpose of this review was to focus on hospital admissions caused by a specific type of adverse drug reaction (ADR) that can be assumed to be avoidable in almost all cases: the drug-drug interaction (D-DI). To determine the epidemiology of D-DIs in hospital admissions, a review of the adverse drug reaction literature was undertaken to answer several questions: (a) what is the incidence of hospital admissions attributable to D-DIs?; (b) what percentage of drug-related hospital admissions are attributable to D-DIs?; (c) are there any patterns to the above findings, i.e. are some D-DIs or specific drugs more likely to have been associated with hospital admissions?; and (d) are there certain patient risk factors (e.g. age) that are associated with D-DIs that led to a hospital admission? Nine ADR studies were found that either included a D-DI category as a cause for hospital admissions, or provided sufficient information so that a causal relationship could be inferred. The incidence of hospital admissions due to D-DIs ranged from 0 to 2.8%. The data found in the studies we reviewed, however, were insufficient to allow meaningful quantification of specific drugs as usual causes for D-DI-related admissions, and because of the very small numbers of patients for which a D-DI was believed to be the cause it is not possible to provide a meaningful summary of risk factors specific for D-DI admissions. We cannot conclude that D-DIs are a significant problem. There is a need to view the quantification of D-DIs in relation to the number of medications prescribed by physicians, dispensed by pharmacists and taken by patients.

摘要

本综述的目的是聚焦于由一类特定的药物不良反应(ADR)导致的住院情况,这类不良反应在几乎所有情况下都可被认为是可以避免的:药物相互作用(D-DI)。为了确定住院患者中药物相互作用的流行病学情况,我们对药物不良反应文献进行了综述,以回答几个问题:(a)因药物相互作用导致的住院发生率是多少?(b)与药物相关的住院病例中,由药物相互作用导致的占比是多少?(c)上述结果是否存在某种模式,即某些药物相互作用或特定药物是否更有可能与住院相关?(d)是否存在某些与导致住院的药物相互作用相关的患者风险因素(如年龄)?我们发现了9项药物不良反应研究,这些研究要么将药物相互作用类别列为住院原因之一,要么提供了足够的信息以便推断因果关系。因药物相互作用导致的住院发生率在0%至2.8%之间。然而,我们所综述的研究中的数据不足以对作为药物相互作用相关住院常见原因的特定药物进行有意义的量化,并且由于被认为是由药物相互作用导致住院的患者数量非常少,所以无法对药物相互作用相关住院特有的风险因素进行有意义的总结。我们不能得出药物相互作用是一个重大问题的结论。有必要结合医生开出、药剂师调配以及患者服用的药物数量来考量药物相互作用的量化情况。

相似文献

1
Epidemiology of drug-drug interactions as a cause of hospital admissions.作为住院原因的药物相互作用的流行病学。
Drug Saf. 1993 Jul;9(1):51-9. doi: 10.2165/00002018-199309010-00005.
2
Hospitalisations and emergency department visits due to drug-drug interactions: a literature review.因药物相互作用导致的住院和急诊就诊:一项文献综述。
Pharmacoepidemiol Drug Saf. 2007 Jun;16(6):641-51. doi: 10.1002/pds.1351.
3
Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.肿瘤人群中的药物不良反应:发生率、可预测性和可预防。
Oncologist. 2019 Sep;24(9):e968-e977. doi: 10.1634/theoncologist.2018-0476. Epub 2019 Mar 4.
4
Drug related hospital admissions in subspecialities of internal medicine.内科各亚专科中与药物相关的住院情况。
Dan Med Bull. 1996 Apr;43(2):141-55.
5
Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.法国药物不良反应导致的住院率:EMIR研究
Fundam Clin Pharmacol. 2015 Feb;29(1):106-11. doi: 10.1111/fcp.12088. Epub 2014 Sep 25.
6
Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis.老年人因药物不良反应导致的住院情况:一项荟萃分析。
Eur J Clin Pharmacol. 2017 Jun;73(6):759-770. doi: 10.1007/s00228-017-2225-3. Epub 2017 Mar 1.
7
Determining the frequency and preventability of adverse drug reaction-related admissions to an Irish University Hospital: a cross-sectional study.确定爱尔兰大学医院中与药物不良反应相关的住院频率和可预防程度:一项横断面研究。
Emerg Med J. 2014 Jan;31(1):24-9. doi: 10.1136/emermed-2012-201945. Epub 2013 Feb 6.
8
[Drug related problems as a cause of hospital admission].[药物相关问题作为住院原因]
Med Clin (Barc). 2002 Feb 23;118(6):205-10.
9
Repeat Adverse Drug Reaction-Related Hospital Admissions in Elderly Australians: A Retrospective Study at the Royal Hobart Hospital.澳大利亚老年人与药物不良反应相关的再次住院情况:皇家霍巴特医院的一项回顾性研究
Drugs Aging. 2017 Oct;34(10):777-783. doi: 10.1007/s40266-017-0490-6.
10
Drug interactions in at-risk emergency department patients.高危急诊科患者的药物相互作用。
Acad Emerg Med. 2002 Nov;9(11):1162-7. doi: 10.1111/j.1553-2712.2002.tb01571.x.

引用本文的文献

1
Drug-Drug Interactions and Their Association with Adverse Health Outcomes in the Older Community-Dwelling Population: A Prospective Cohort Study.药物-药物相互作用及其与老年社区居民不良健康结局的关联:一项前瞻性队列研究。
Clin Drug Investig. 2024 Jun;44(6):439-453. doi: 10.1007/s40261-024-01369-9. Epub 2024 Jun 15.
2
Pharmacologic Stewardship in a Rural Community Pharmacy.农村社区药房的药物管理
Healthcare (Basel). 2023 Sep 25;11(19):2619. doi: 10.3390/healthcare11192619.
3
The heterogeneous pharmacological medical biochemical network PharMeBINet.

本文引用的文献

1
Drug utilization in office practice by age and sex of the patient: National Ambulatory Medical Care Survey, 1980.按患者年龄和性别划分的门诊医疗实践中的药物使用情况:1980年国家门诊医疗调查
Adv Data. 1982 Jul 26(81):1-11.
2
Drug interactions: a retrospective study of its epidemiology, clinical significance and influence upon hospitalization.药物相互作用:对其流行病学、临床意义及对住院治疗影响的回顾性研究
Can J Hosp Pharm. 1979 Jan-Feb;32(1):12-6.
3
The role of iatrogenic disease in admissions to intensive care.医源性疾病在重症监护病房收治患者中的作用。
异质药理学医学生物化学网络 PharMeBINet。
Sci Data. 2022 Jul 11;9(1):393. doi: 10.1038/s41597-022-01510-3.
4
Drug-Drug Interactions among Kidney Transplant Recipients in The Outpatient Setting.门诊环境下肾移植受者的药物相互作用
Int J Organ Transplant Med. 2020;11(4):185-195.
5
Universal Patient Identifier and Interoperability for Detection of Serious Drug Interactions: Retrospective Study.用于检测严重药物相互作用的通用患者标识符与互操作性:回顾性研究
JMIR Med Inform. 2020 Nov 20;8(11):e23353. doi: 10.2196/23353.
6
A Population-Based Study of Simvastatin Drug-Drug Interactions in Cardiovascular Disease Patients.一项基于人群的心血管疾病患者辛伐他汀药物相互作用研究。
AMIA Jt Summits Transl Sci Proc. 2020 May 30;2020:664-673. eCollection 2020.
7
Are drug-drug interactions a real clinical concern?药物相互作用是一个真正的临床问题吗?
Perspect Clin Res. 2019 Apr-Jun;10(2):62-66. doi: 10.4103/picr.PICR_55_18.
8
Potential Drug-Drug Interactions among Patients prescriptions collected from Medicine Out-patient Setting.从内科门诊收集的患者处方之间的潜在药物相互作用。
Pak J Med Sci. 2018 Jan-Feb;34(1):144-148. doi: 10.12669/pjms.341.13986.
9
Potential drug-drug interactions among hospitalized patients in a developing country.发展中国家住院患者中潜在的药物相互作用。
Caspian J Intern Med. 2017 Fall;8(4):282-288. doi: 10.22088/cjim.8.4.282.
10
Systemic anticancer therapy (SACT) for lung cancer and its potential for interactions with other medicines.肺癌的全身抗癌治疗(SACT)及其与其他药物相互作用的可能性。
Ecancermedicalscience. 2017 Sep 4;11:764. doi: 10.3332/ecancer.2017.764. eCollection 2017.
JAMA. 1980 Dec 12;244(23):2617-20.
4
Drug-related problems causing admission to a medical clinic.导致入住医疗诊所的药物相关问题。
Eur J Clin Pharmacol. 1981;20(3):193-200. doi: 10.1007/BF00544597.
5
Adverse drug reactions among the elderly: a reassessment.老年人中的药物不良反应:重新评估
J Am Geriatr Soc. 1981 Nov;29(11):525-30. doi: 10.1111/j.1532-5415.1981.tb03356.x.
6
Adverse drug reactions: the magnitude of the problem.药物不良反应:问题的严重程度。
J Allergy Clin Immunol. 1984 Oct;74(4 Pt 2):555-7. doi: 10.1016/0091-6749(84)90106-4.
7
Adverse drug reactions during hospitalization.住院期间的药物不良反应。
Can Med Assoc J. 1967 Dec 9;97(24):1450-7.
8
Studies on the epidemiology of adverse drug reactions. V. Clinical factors influencing susceptibility.药物不良反应的流行病学研究。V. 影响易感性的临床因素。
Ann Intern Med. 1966 Oct;65(4):629-40. doi: 10.7326/0003-4819-65-4-629.
9
Predisposing factors in adverse reactions to drugs.药物不良反应的诱发因素。
Br Med J. 1969 Mar 1;1(5643):536-9. doi: 10.1136/bmj.1.5643.536.
10
Assessment of adverse reactions within a drug surveillance program.药物监测计划中不良反应的评估。
JAMA. 1968 Aug 26;205(9):645-7.